![]() |
|||||||||||||||||||||
|
|||||||||||||||||||||
AXA Private Equity, in association with Eliokem’s management team headed by its CEO, Jacques Collonge, signed a share purchase agreement with the American private equity firm, Littlejohn & Co. LLC, to acquire Eliokem, the specialty chemical group, through a Leveraged Buy-Out (LBO) transaction for approximately €130 million. Eliokem is a specialty chemical group with headquarters in Villejust near Paris, France. The group employs more than 460 people around the world and owns 3 production facilities located at Le Havre (France), Akron (Ohio, USA) and Ningbo (China), as well as 6 representative offices in Europe, Asia and The Americas, and a network of 75 distributors and agents strategically located around the world. In 2005, the company achieved a turnover of €148 million, up 7% compared to 2004. Eliokem expects a similar growth in 2006. The Eliokem management team remains unchanged with, Jacques Collonge as President CEO, Philippe Carabin, Chief Financial Officier, Rick Sandford, Commercial Director, Olivier Faussadier, Manufacturing & Technology Director and Anne Chaumeret, Human Resource Director. Eliokem’s brands and products have made it a leader in numerous specific
applications: Pliolite®, Plioway®, Pliotec® and Hydro Pliolite® (coatings
resins), Pliocord®, et Chemigum® (latices), Chemigum®, Sunigum® (elastomer
modifiers) and Wingstay® (antioxidants). “We chose AXA Private Equity because we are convinced that they are the right partners to bring us the support that we need to grow organically with our customers and externally through acquisitions in fast-growing markets” stated Jacques Collonge, President CEO of Eliokem. At AXA Private Equity, Thibault Basquin and Bruno Ladrière underline “we are
very happy to have completed this acquisition as Eliokem’s products enjoy
leading market positions and set the performance standards in several niche
markets with high growth potential. This is made possible thanks to the sound
experience of its teams, the well-known brands of the company, its R&D
state-of-the-art competencies, and the excellent customer relationships
developed through its distribution networks and suppliers. Following its
successful carve-out from Goodyear, our ambition is that Eliokem become a strong
development platform, mainly through external growth projects with a view to
reinforcing its position in several market segments and geographic zones such as
Asia, the USA, and Eastern Europe”. About Eliokem: Eliokem is a leading Specialty Chemical company Eliokem’s brands and products have made it a leader in numerous specific applications:
Press Contacts: AXA Private Equity: Eliokem: List of people and advisors involved in the Eliokem transaction: 1. Purchaser: AXA Private Equity: Thibault Basquin, Bruno Ladrière Advisors for AXA Private Equity:
2. Sellers: Littlejohn & Co. LLC: Michael I. Klein, David E. Simon Seller’s advisors:
3. Senior and Mezzanine financings: - SG CIB: Nicolas de Saint-Laon, Xavier Morin - Legal advisor for SG CIB: Linklaters (Arnaud Fromion, Eric Fiszelson) 4. Management: - Management legal advisor: De Pardieu Brocas Maffei (Jean-François Pourdieu, Thibaut Caharel) |
|
||||||||||||||||||||